Subjects: Buprenorphine - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Buprenorphine

1. The risk of misuse and diversion of buprenorphine for opioid use disorder appears to be low in Medicare Part D

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2023
Subject(s):: Buprenorphine
Buprenorphine, Naloxone Drug Combination
Government Regulation
Medicare Part D
Opioid-Related Disorders -- drug therapy
United States

2. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States